VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med. 2000 Sep 25; 160(17):2659-64.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Amphotericin B
Antifungal Agents
Antineoplastic Agents
Candida albicans
Case-Control Studies
Catheterization, Central Venous
Catheters, Indwelling
Child
Child, Preschool
Drug Resistance, Microbial
Female
Fluconazole
Fungemia
Hematologic Neoplasms
Humans
Immunocompromised Host
Immunosuppressive Agents
Infant
Logistic Models
Male
Middle Aged
Neutropenia
Prognosis
Retrospective Studies
Risk Factors
Shock, Septic
Treatment Outcome
authors with profiles
RAY Y HACHEM
DIMA SUKI